Acquired thrombocytopenia after transcatheter aortic valve replacement: Clinical correlates and association with outcomes

European Heart Journal

Volumn 35, Issue 38, 2014, Pages 2663-2671

  Dvir, Danny ^a   Généreux, Philippe ^b   Barbash, Israel M ^a   Kodali, Susheel ^b   Ben Dor, Itsik ^a   Williams, Mathew ^b   Torguson, Rebecca ^a   Kirtane, Ajay J ^b   Minha, Sa'ar ^a   Badr, Salem ^a   Pendyala, Lakshmana K ^a   Loh, Joshua P ^a   Okubagzi, Petros G ^a   Fields, Jessica N ^a   Xu, Ke ^b   Chen, Fang ^a   Hahn, Rebecca T ^b   Satler, Lowell F ^a   Smith, Craig ^b   Pichard, Augusto D ^a   Leon, Martin B ^b   Waksman, Ron ^a   more..

^a WASHINGTON HOSPITAL CENTER   (United States)

^b Department of Medicine   (United States)

Author keywords

Thrombocytopenia; Transcatheter aortic valve replacement

Indexed keywords

AGED; ARTICLE; CANCER INCIDENCE; CLINICAL FEATURE; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TRANSCATHETER AORTIC VALVE IMPLANTATION; ADVERSE EFFECTS; AORTIC VALVE STENOSIS; CLINICAL TRIAL; LENGTH OF STAY; MULTICENTER STUDY; TREATMENT OUTCOME; VERY ELDERLY;

AGED, 80 AND OVER; AORTIC VALVE STENOSIS; FEMALE; HUMANS; LENGTH OF STAY; MALE; PLATELET COUNT; THROMBOCYTOPENIA; TRANSCATHETER AORTIC VALVE REPLACEMENT; TREATMENT OUTCOME;

EID: 84928412740     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehu082     Document Type: Article

References (31)

1. Kodali SK, Williams MR, Smith CR, Svensson LG,Webb JG, Makkar RR, Fontana GP, Dewey TM, Thourani VH, Pichard AD, Fischbein M, Szeto WY, Lim S, Greason KL, Teirstein PS, Malaisrie SC, Douglas PS, Hahn RT, Whisenant B, Zajarias A,Wang D, Akin JJ, AndersonWN,Leon MB; PARTNERTrial Investigators. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 2012;366: 1686-1695.
2. Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, Leprince P, Leguerrier A, Lievre M, PratA,Teiger E, LefevreT, Himbert D, Tchetche D, Carrié D, Albat B, Cribier A, Rioufol G, Sudre A, Blanchard D, Collet F, Dos Santos P, Meneveau N, Tirouvanziam A, Caussin C, Guyon P, Boschat J, Le Breton H, Collart F, Houel R, Delpine S, Souteyrand G, Favereau X, Ohlmann P, Doisy V, Grollier G, Gommeaux A, Claudel JP, Bourlon F, Bertrand B, Van Belle E, Laskar M. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med 2012;366:1705-1715.
3. Zahn R, Gerckens U, Grube E, Linke A, Sievert H, Eggebrecht H, Hambrecht R, Sack S, Hauptmann KE, Richardt G, Figulla HR, Senges J. Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur Heart J 2011; 32:198-204.
4. Reinöhl J, Gutmann A, Kollum M, von ZurMühlen C, Baumbach H,Avlar M, Moser M, Bode C, Zehender M. Transfemoral aortic valve implantation: bleeding events, related costs and outcomes. J Thromb Thrombolysis 2013;35:469-475.
5. Elhmidi Y, Bleiziffer S, Piazza N, Hutter A, Opitz A, Hettich I, Kornek M, Ruge H, Brockmann G, Mazzitelli D, Lange R. Incidence and predictors of acute kidney injury in patients undergoing transcatheter aortic valve implantation. Am Heart J 2011;161:735-739.
6. Stortecky S, Buellesfeld L,Wenaweser P, Windecker S. Transcatheter aortic valve implantation: prevention and management of complications. Heart 2012;98 (Suppl. 4):iv52-iv64.
7. Guinot PG, Depoix JP, Etchegoyen L, Benbara A, Provenchère S, Dilly MP, Philip I, Enguerand D, Ibrahim H, Vahanian A, Himbert D, Al-Attar N, Nataf P, Desmonts JM, Montravers P, Longrois D. Anesthesia and perioperative management of patients undergoing transcatheter aortic valve implantation: analysis of 90 consecutive patients with focus on perioperative complications. J Cardiothorac Vasc Anesth 2010;24:752-761.
8. Crowther MA, Cook DJ, Meade MO, Griffith LE, Guyatt GH, Arnold DM, Rabbat CG, GeertsWH,Warkentin TE. Thrombocytopenia in medical-surgical critically ill patients: prevalence, incidence, and risk factors. J Crit Care 2005;20:348-353.
9. Drews RE, Weinberger SE. Thrombocytopenic disorders in critically ill patients. Am J Respir Crit Care Med 2000;162(2 Pt 1):347-351.
10. Matthai WH Jr. Thrombocytopenia in cardiovascular patients: diagnosis and management. Chest 2005;127(2 suppl):46S-52S.
11. Martin JF, Daniel TD, Trowbridge EA. Acute and chronic changes in platelet volume and count after cardiopulmonary bypass induced thrombocytopenia in man. Thromb Haemost 1987;57:55-58.
12. De Labriolle A, Bonello L, Lemesle G, Roy P, Steinberg DH, Xue Z, Suddath WO, Satler LF, Kent KM, Pichard AD, Lindsay J, Waksman R. Decline in platelet count in patients treated by percutaneous coronary intervention: definition, incidence, prognostic importance, and predictive factors. Eur Heart J 2010;31:1079-1087.
13. Li P, Chen F, Zhao X, Zheng X, Wu H, Chen S, Qin Y. Occurrence and clinical significance of in-hospital acquired thrombocytopenia in patients undergoing transcatheter device closure for congenital heart defect. Thromb Res 2012;130:882-888.
14. Kappetein AP, Head SJ, Généreux P, Piazza N, van Mieghem NM, Blackstone EH, Brott TG, Cohen DJ, Cutlip DE, van Es GA, Hahn RT, Kirtane AJ, Krucoff MW, Kodali S, Mack MJ, Mehran R, Rodés-Cabau J, Vranckx P, Webb JG, Windecker S, SerruysPW, Leon MB. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol 2012;60:1438-1454.
15. Arepally GM, Ortel TL. Clinical practice. Heparin-induced thrombocytopenia. N Engl J Med 2006;355:809-817.
16. Gallet R, Seemann A, Yamamoto M, Hayat D, Mouillet G, Monin JL, Gueret P, Couetil JP, Dubois-Randé JL, Teiger E, Lim P. Effect of transcatheter (via femoral artery) aortic valve implantation on the platelet count and its consequences. Am J Cardiol 2013;111:1619-1624.
17. van Straten AH, Hamad MA, Berreklouw E, ter Woorst JF, Martens EJ, Tan ME. Thrombocytopenia after aortic valve replacement: comparison between mechanical and biological valves. J Heart Valve Dis 2010;19:394-399.
18. Rezende E, Morais G, Silva Junior JM, Oliveira AM, Souza JM, Toledo DO, Richter I, Brandão EM. Thrombocytopenia in cardiac surgery: diagnostic and prognostic importance. Rev Bras Cir Cardiovasc 2011;26:47-53.
19. Stone GW, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Kornowski R, Hartmann F, Gersh BJ, Pocock SJ, Dangas G, Wong SC, Kirtane AJ, Parise H, Mehran R. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med 2008;358:2218-2230.
20. McClure MW, Berkowitz SD, Sparapani R, Tuttle R, Kleiman NS, Berdan LG, Lincoff AM, Deckers J, Diaz R, Karsch KR, Gretler D, Kitt M, Simoons M, Topol EJ, Califf RM, Harrington RA. Clinical significance of thrombocytopenia during a non-ST-elevation acute coronary syndrome: the Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrelin Therapy (PURSUIT) trial experience. Circulation 1999;99:2892-2900.
21. YehRW, Wiviott SD, Guigliano RP, Morrow DA, Shui A, Qin J, Scirica B, Bradner JE, Jang I, Gibson CM, Antman EM. Effect of thrombocytopenia on outcomes following treatment with either enoxaparin or unfractionated heparin in patients presenting with acute coronary syndromes. Am J Cardiol 2007;100:1734-1738.
22. Harrington RA, Sane DC, Califf RM, Sigmon KN, Abbottsmith CW, Candela RJ, Lee KL, Topol EJ. Clinical importance of thrombocytopenia occurring in the hospital phase after administration of thrombolytic therapy for acute myocardial infarction: the Thrombolysis and Angioplasty in Myocardial Infarction Study Group. J Am Coll Cardiol 1994;23:891-898.
23. Nikolsky E, Sadeghi HM, Effron MB, Mehran R, Lansky AJ, Na Y, Cox DA, Garcia E, Tcheng JE, Griffin JJ, Stuckey TD, Turco M, Carroll JD, Grines CL, StoneGW. Impact of in-hospital acquired thrombocytopenia in patients undergoing primary angioplasty for acute myocardial infarction. Am J Cardiol 2005;96:474-481.
24. Kuter DJ. The physiology of platelet production. Stem Cells 1996;14 (Suppl. 1): 88-101.
25. Aregger F,Wenaweser P, Hellige GJ, Kadner A, CarrelT, Windecker S, Frey FJ. Risk of acute kidney injury in patients with severe aortic valve stenosis undergoing transcatheter valve replacement. Nephrol Dial Transplant 2009;24:2175-2179.
26. Van Linden A, Kempfert J, Rastan AJ, Holzhey D, Blumenstein J, Schuler G, MohrFW, Walther T. Risk of acute kidney injury after minimally invasive transapical aortic valve implantation in 270 patients. Eur J Cardiothorac Surg 2011;39:835-842.
27. François B, Trimoreau F, Vignon P, Fixe P, Praloran V, Gastinne H. Thrombocytopenia in the sepsis syndrome: role of hemophagocytosis and macrophage colony-stimulating factor. Am J Med 1997;103:114-120.
28. Neunert C, LimW, Crowther M, Cohen A, Solberg L Jr, Crowther MA. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 2011;117:4190-4207.
29. Sinning JM, Scheer AC, Adenauer V, Ghanem A, Hammerstingl C, Schueler R, Müller C, Vasa-Nicotera M, Grube E, Nickenig G,Werner N. Systemic inflammatory response syndrome predicts increased mortality in patients after transcatheter aortic valve implantation. Eur Heart J 2012;33:1459-1468.
30. Linkins LA, Dans AL, Moores LK, Bona R, Davidson BL, Schulman S, Crowther M. Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141(2 suppl): e495S-e530S.
31. Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia and cardiac surgery. Ann Thorac Surg 2003;76:2121-2131.